 |
|
|
|
|
|
 |
Learn about our UK operations.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Explore opportunities in our entreprenuerial culture.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Learn what's new for Genzyme in the UK.
|
|
|
|
|
|
|
|
|
|
|
|
 |
Find out what is new in our research and development.
|
|
|
|
|
|
|
|
Genzyme
Genzyme and NHS National Commissioning Group form a £7 million Partnership to support world class commissioning for rare diseases
As a result of successful negotiations between DH and the biotechnology company, Genzyme, the NHS National Commissioning Group today announced that they will join together in a £7m partnership to support a specialised system of care for patients with Lysosomal Storage Disorders (LSDs). More>
|
Genzyme Open Day to Celebrate Expansion at Oxford Site
Genzyme today announced the official opening of its expanded facilities at the Oxford Business Park by Andrew Smith, MP for Oxford East, during an Open Day attended by the local business community, healthcare professionals and patient groups. The new facilities reflect the continued growth of Genzyme in the UK where the Company supplies innovative products for the management of chronically debilitating diseases including genetic disorders, renal disease and thyroid cancer. More>
|
Genzyme is pleased to announce the EWGGD meeting to be held at St John’s College, Cambridge.
This prestigious European meeting will have as attendees all those who are connected to the world of Gaucher disease and lysosomal storage disorders. Further information on registration can be obtained via this link.
Genzyme is pleased to announce that we are platinum sponsors of this event. Please note that the call for abstracts is currently active. The closing date is 12th May.
|
|
|
Genzyme UK Home
Genzyme Corporate Home
